» Articles » PMID: 22303359

Dystrophin Orchestrates the Epigenetic Profile of Muscle Cells Via MiRNAs

Overview
Journal Front Genet
Date 2012 Feb 4
PMID 22303359
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

Mammalian musculature is a very robust and dynamic tissue that goes through many rounds of degeneration and regeneration in an individual's lifetime. There is a biological program that maintains muscle progenitor cells that, when activated, give rise to intermediate myoblast progeny that consequently differentiate into mature muscle cells. Recent works have provided a picture of the role that microRNAs (miRNAs) play in maintaining aspects of this program. Intriguingly, a subset of these miRNAs is de-regulated in muscular dystrophies (MDs), a group of fatal inherited neuromuscular disorders that are often associated with deficiencies in the Dystrophin (Dys) complex. Apparently, transcriptional expression of many of the muscle specific genes and miRNAs is dependent on chromatin state regulated by the Dys-Syn-nNOS pathway. This puts Dystrophin at the epicenter of a highly regulated program of muscle gene expression in which miRNAs help to coordinate networking between multiple phases of muscle maintenance, degeneration, and regeneration. Therefore, understanding the role of miRNAs in physiology of normal and diseased muscle tissue could be useful for future applications in improving the MD therapies and could open new clinical perspectives.

Citing Articles

Histone deacetylase inhibition with givinostat: a multi-targeted mode of action with the potential to halt the pathological cascade of Duchenne muscular dystrophy.

Aartsma-Rus A Front Cell Dev Biol. 2025; 12():1514898.

PMID: 39834392 PMC: 11743666. DOI: 10.3389/fcell.2024.1514898.


Key concepts in muscle regeneration: muscle "cellular ecology" integrates a gestalt of cellular cross-talk, motility, and activity to remodel structure and restore function.

Anderson J Eur J Appl Physiol. 2021; 122(2):273-300.

PMID: 34928395 PMC: 8685813. DOI: 10.1007/s00421-021-04865-4.


Therapeutic aspects of cell signaling and communication in Duchenne muscular dystrophy.

Starosta A, Konieczny P Cell Mol Life Sci. 2021; 78(11):4867-4891.

PMID: 33825942 PMC: 8233280. DOI: 10.1007/s00018-021-03821-x.


Exocyst-mediated membrane trafficking of the lissencephaly-associated ECM receptor dystroglycan is required for proper brain compartmentalization.

Yatsenko A, Kucherenko M, Xie Y, Urlaub H, Shcherbata H Elife. 2021; 10.

PMID: 33620318 PMC: 7929561. DOI: 10.7554/eLife.63868.


Profiling of the muscle-specific dystroglycan interactome reveals the role of Hippo signaling in muscular dystrophy and age-dependent muscle atrophy.

Yatsenko A, Kucherenko M, Xie Y, Aweida D, Urlaub H, Scheibe R BMC Med. 2020; 18(1):8.

PMID: 31959160 PMC: 6971923. DOI: 10.1186/s12916-019-1478-3.


References
1.
Pfeifer A, Lehmann H . Pharmacological potential of RNAi--focus on miRNA. Pharmacol Ther. 2010; 126(3):217-27. DOI: 10.1016/j.pharmthera.2010.03.006. View

2.
Cacchiarelli D, Martone J, Girardi E, Cesana M, Incitti T, Morlando M . MicroRNAs involved in molecular circuitries relevant for the Duchenne muscular dystrophy pathogenesis are controlled by the dystrophin/nNOS pathway. Cell Metab. 2010; 12(4):341-351. DOI: 10.1016/j.cmet.2010.07.008. View

3.
Greco S, De Simone M, Colussi C, Zaccagnini G, Fasanaro P, Pescatori M . Common micro-RNA signature in skeletal muscle damage and regeneration induced by Duchenne muscular dystrophy and acute ischemia. FASEB J. 2009; 23(10):3335-46. DOI: 10.1096/fj.08-128579. View

4.
Krutzfeldt J, Rajewsky N, Braich R, Rajeev K, Tuschl T, Manoharan M . Silencing of microRNAs in vivo with 'antagomirs'. Nature. 2005; 438(7068):685-9. DOI: 10.1038/nature04303. View

5.
Yuasa K, Hagiwara Y, Ando M, Nakamura A, Takeda S, Hijikata T . MicroRNA-206 is highly expressed in newly formed muscle fibers: implications regarding potential for muscle regeneration and maturation in muscular dystrophy. Cell Struct Funct. 2008; 33(2):163-9. DOI: 10.1247/csf.08022. View